The question patients ask first about telehealth peptides is almost always cost. Not the molecular mechanism, not the FDA regulatory category, not the difference between Section 503A and 503B pharmacy compounding. Cost.
This article is the honest accounting. It walks through typical 2026 program-level pricing across the four most common telehealth peptide categories, explains exactly what is and is not included in the price, describes why insurance generally does not cover compounded peptide therapy, and lays out the math for comparing month-to-month enrollment against prepay and annual structures.
What the article does not do is compare compounded preparations to branded FDA-approved finished drug products by name or price. That comparison is not a meaningful one — compounded preparations and branded FDA-approved drugs occupy different regulatory categories under federal law, and per the FDA's February 6 2026 guidance, compounded products may not be marketed by comparison to branded products. The pricing here is for the compounded program category on its own terms.
Typical 2026 telehealth peptide program pricing
Telehealth peptide therapy is typically priced as a flat monthly program fee rather than a per-prescription unit cost. The flat fee aligns the patient's payment with what the program actually delivers: a continuing prescriber relationship, ongoing medication supply, and scheduled follow-up. Below are representative ranges across the four most common program categories TelePeptide offers.
Compounded GLP-1 receptor agonist programs
Programs centered on compounded semaglutide or tirzepatide are the most commonly searched telehealth peptide pricing category. Typical 2026 monthly ranges:
- Entry / microdose program: roughly $199 to $299 per month. Lower compounded doses, monthly fills, suitable for the initial titration window.
- Standard program: roughly $299 to $449 per month. Standard prescribed doses for ongoing metabolic care, with prescriber-led titration.
- Advanced program: roughly $449 to $599 per month. Higher prescribed doses where clinically appropriate.
These ranges reflect the compounded preparation specifically. Branded GLP-1 finished drug products are priced separately by their manufacturers and dispensed through retail or specialty pharmacies; TelePeptide does not dispense branded finished drug products. The two categories are not interchangeable and not directly comparable on price.
Sermorelin (GHRH analog) endocrine programs
Sermorelin is a growth-hormone-releasing hormone analog prescribed under endocrine evaluation for documented age-related GHRH-axis decline. The TelePeptide formulary includes sermorelin only within an endocrine-axis framing under prescriber supervision. Typical 2026 monthly ranges:
- Entry program: roughly $199 to $249 per month. Standard dosing under prescriber supervision.
- Standard program: roughly $249 to $349 per month. Includes endocrine follow-up labs at clinically appropriate intervals.
Sermorelin formulations are typically simpler to compound than GLP-1 receptor agonists, which is why the average monthly price runs lower for sermorelin programs at comparable dosing frequency.
NAD+ subcutaneous protocols
NAD+ telehealth protocols vary in dose and frequency. Typical 2026 monthly ranges:
- Entry program: $200 to $300 per month, typically 50 to 100 mg twice weekly.
- Standard program: $300 to $400 per month, typically 100 mg twice or three times weekly.
- High-dose program: $400 to $600 per month, with per-session dose at 150 to 200 mg.
The per-milligram math and the structural cost difference between subcutaneous protocols and clinic IV infusions is covered in detail in our NAD+ cost breakdown article.
FAQ
Common questions
How much do telehealth peptides cost in 2026?
Typical telehealth peptide program pricing in 2026 runs roughly $199 to $599 per month depending on the formulation, dose, and program tier. Compounded GLP-1 receptor agonist programs typically run $299 to $599 per month. Sermorelin endocrine programs typically run $199 to $349 per month. NAD+ subcutaneous protocols typically run $200 to $500 per month. B12/MIC nutrient programs typically run $99 to $199 per month. Each program's flat monthly fee bundles the clinical evaluation, prescription, compounded medication, dispensing, shipping, and ongoing prescriber access.
What is included in a telehealth peptide therapy monthly fee?
A standard inclusion bundle: the initial clinical evaluation (intake review, asynchronous or synchronous as state law requires), the patient-specific prescription, the compounded medication from a state-licensed Section 503A pharmacy, supplies (syringes, alcohol swabs), temperature-controlled overnight shipping where required, prescriber-portal messaging access, and scheduled follow-up at clinically appropriate intervals.
What is NOT included in the monthly fee?
Additional lab work beyond the initial panel (separately billed at the lab's cash-pay rate, typically $50–$300 per panel), dose escalations that change the prescribed formulation strength (may trigger a new prescription cycle), ancillary care for unrelated conditions, in-person physical exams (TelePeptide is a telemedicine platform), specialist referrals, and any care outside the prescriber's scope.
Why does the price vary so much between programs?
Four drivers: (1) Active ingredient cost — compounded GLP-1 receptor agonists have a higher API cost than simpler nutrient preparations. (2) Compounding complexity — sterile injectables under USP <797> cost more to prepare than non-sterile oral or sublingual formulations under USP <795>. (3) Dose — higher doses use more active ingredient per fill. (4) Program duration — prepay and annual programs typically carry a per-month discount versus month-to-month enrollment.
Why doesn't insurance cover compounded telehealth peptide therapy?
Compounded peptide preparations are not FDA-approved finished drug products, and most insurance carriers limit coverage to FDA-approved drugs prescribed for FDA-approved indications. Compounded preparations occupy a separate regulatory category under FDCA Section 503A and are generally outside insurance formularies regardless of clinical appropriateness. FSA and HSA accounts sometimes reimburse compounded peptide therapy when the prescriber documents a qualifying medical diagnosis, but coverage is the exception rather than the rule.
What does "cash-pay" actually mean for telehealth peptides?
Cash-pay means the patient pays the program fee directly to the telehealth provider — without going through an insurance carrier — and without seeking insurance reimbursement after the fact. The price the patient sees is the price the patient pays. There is no claims cycle, no deductible to meet, no copay structure, and no prior authorization. The trade-off is that the patient bears the full cost; the benefit is pricing transparency, no surprise EOBs, and access to compounded formulations insurance would not cover anyway.
Next Step
Talk to a TelePeptide Doctor
A licensed clinician will review your goals and recommend the right protocol — peptide wellness, recomposition, or supervised weight loss. No insurance, no waiting room.
TelePeptide offers direct-pay telehealth services. All medications are compounded by licensed 503A pharmacies. Prescribing decisions are made solely by licensed clinicians based on individual medical necessity. These statements have not been evaluated by the FDA. Compounded medications are not FDA-approved.